Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
 
 

Frontiers in Multiple Sclerosis: New and Emerging Therapies CME/CE

Release Date: August 31, 2007; Valid for credit through August 31, 2008

Authors: Bruce Cree, MD, PhD, MCR; Bruce A. Cohen, MD; Patricia K. Coyle, MD; Clyde E. Markowitz, MD Author Information and Disclosures

This online activity is based on presentations at the CME/CE symposium titled "Frontiers in Multiple Sclerosis: New and Emerging Therapies" on Thursday, May 31, 2007, at the Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting in Washington, DC. Persons in attendance at the symposium are NOT eligible for AMA PRA Category 1 Credit™ for completing this enduring material. The CMSC has reviewed and approved this report as appropriate for presentation as a spin-off of an Industry Supported Symposium. The report reflects the content and views of the sponsor and is not part of the official CMSC Annual Meeting program. This activity has been approved for AMA PRA Category 1 Credit™.

Contents of This CME/CE Activity

All sections of this activity are required for credit.
  1. Evolving Views of MS Pathogenesis by Bruce A. Cohen, MD
  2. Emerging Oral Options for MS Therapy by Bruce Cree, MD, PhD, MCR
  3. Novel Intravenous and Antibody-Based MS Therapies by Clyde E. Markowitz, MD
  4. Where Do They Fit In? Potential Clinical Place of Emerging Therapies by Patricia K. Coyle, MD

Go to CME/CE Test Questions

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2007 Medical Education Collaborative, Inc.

EMD

This program is sponsored by MEC. This activity was developed in collaboration with Medical Education Collaborative and the Discovery Institute of Medical Education, New York Office

Medical Education Collaborative, Inc. (MEC) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

MEC designates this educational activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

MEC is the accredited provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. RNs, LPNs, LVNs, and NPs can receive up to 1.7 contact hours for participation in this program.

Provider approved by the California Board of Registered Nursing, Provider Number CEP 12990, for 2.0 contact hour(s).